Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is pleased to announce the invitation for qualified international consulting firms to participate in the Consultant Selection Process for the Bidiphar Sterile Injectable Facility (SVI) EU GMP Project.

 

The project is part of Bidiphar’s strategic development program to strengthen sterile pharmaceutical manufacturing capabilities and support future compliance with European Union Good Manufacturing Practice (EU GMP) requirements.

 

The expected consultancy scope includes, but is not limited to, EU GMP readiness assessment, facility and cleanroom review, Commissioning, Qualification and Validation (CQV), Contamination Control Strategy (CCS), Quality Management System/Pharmaceutical Quality System (QMS/PQS), technology transfer, regulatory readiness, inspection readiness, training, knowledge transfer and post-certification compliance support.

 

Interested consulting firms with relevant experience in EU GMP sterile pharmaceutical projects are invited to confirm their participation and submit the required preliminary information in accordance with the invitation documents.

 

Deadline for Confirmation of Participation: 04 July 2026, 17:00 Vietnam Time (GMT+7)

Upon receipt and review of the confirmation documents, Bidiphar will issue the complete Request for Proposal (RFP) package to qualified consulting firms.

 

For further information, please contact:

 

Mr. Tran Dinh Khai
Project Management Department
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar)
Email: khaitd@bidiphar.com
Mobile: +84 979 791 299
WhatsApp | Viber | Zalo | WeChat